Background: Glutamatergic dysfunction, deregulated mitochondrial metabolism and alterations of membrane phospholipids are considered as core pathology of psychosis, and have been studied in schizophrenic illness using magnetic resonance spectroscopy (MRS). Combining 1H-and 31P-MRS, this study investigates these aspects in Ultra-high risk (UHR-T) patients right after transition to psychosis (T0) and after a two years interval (T1) in a naturalistic longitudinal design, including treatment as usual by cognitive-behavioral therapy (CBT) and pharmacotherapy with second generation antipsychotics. Methods: We applied 3 T chemical shift imaging (3D 31P-MRS, 2D 1H-MRS) and hippocampal single-voxel 1H-MRS in 29 neurolepticnaïve UHR-T patients and 27 healthy controls matched for age and gender. Glutamate (Glu) and N-acetyl-aspartate (NAA) reflect neuronal functioning, phosphocreatine (PCr), adenosine triphosphate (ATP) and NAA indicate mitochondrial function and energy metabolism, and phosphomono-and diester indicate the balance of phospholipid synthesis (PME) and -breakdown (PDE). Psychopathology was assessed using the CAARMS, BPRS-E and SCL-90-R. Generalized linear mixed models were used to examine case-control differences in metabolite changes over time, and associations with clinical improvement. Results: At T0, cross-sectional analysis revealed decreased NAA, Glu and PME levels in the left dorsolateral prefrontal cortex (DLPFC) and thalamus of UHR-T patients as well as higher PCr and lower PDE levels in the right hippocampus. (ii) Follow-up analysis (T1) showed in patients a significant increase of Glu in the bilateral DLPFC and the right thalamus, while a decrease of PCr was observed in the right hippocampus. Discussion: The observed metabolite pattern at T0 likely reflects a hypofunction of glutamatergic neurons and a disturbance of membrane phospholipid turnover in fronto-thalamo-hippocampal networks during the first acute onset phase of psychotic illness. The pattern of changes at T1 is suggestive for an improvement of neuronal functioning in these networks that is caused by therapy, and presumably underlies the observed clinical improvement in terms of negative symptoms and cognitive impairment.
T24. REDOX REGULATORS AND OXIDATIVE
Background: Elevated levels of oxidative stress have been reported in schizophrenia and may play a role in the underlying psychopathology. The antioxidant defense system may be disrupted in schizophrenia. We have earlier shown how levels of membrane polyunsaturated fatty acids (PUFA) change during the course of schizophrenia, increasing from a low level in a subgroup, remaining stable in another. Here, we aimed at comparing levels of redox regulators, oxidative stress, and related genotypes in schizophrenia patients and healthy controls, and at identifying how these biomarkers are related to membrane fatty acids and clinical characteristics in acute and chronic phase of schizophrenia. Methods: Patients with schizophrenia spectrum disorders (n=55) examined during an acute phase and five years later during a chronic phase, and healthy controls (n=51) were included. We assessed blood levels of redox regulators [(alpha-tocopherol, bilirubin, uric acid, glutathione (GSH) , glutathione peroxidase (GPx)], glutathione reductase (GR), markers of oxidative stress [F2-isoprostane, reactive oxygen metabolites (D-ROMs)] and PUFA. We examined genotypes and gene expression related to glutamate cysteine ligase (GCL), the rate-limiting enzyme of GSH synthesis, and its catalytic (GCLC) and modulator (GCLM) subunits. Links between redox measures and Positive and Negative Syndrome Scale (PANSS) were studied. Results: In the chronic phase, levels of alpha-tocopherol (p=0.03) and bilirubin (p<0.001) were lower, while uric acid (p=0.02) was higher in patients than in controls. In patients, the levels of alpha-tocopherol were higher in the acute phase than in the chronic phase (p=0.001). However, the changes depended on the PUFA levels in the acute phase. In the low PUFA group, alpha-tocopherol levels remained stable, whereas in the high PUFA group, they decreased to those of the low PUFA group. Levels of D-ROMs were linked to PUFA (r=0.39, p=0.007) and long-chain PUFA (r=0.42, p=0.003) in controls but not in patients. There was no significant difference in the distribution of GCLC genotypes between patients and controls. Compared to other GAG trinucleotiderepeat (TNR) genotypes, 7/9 GAG genotype was linked to higher gene expression of GCL (mRNA GCLC, p=0.049; mRNA GCLM, p=0.02), higher levels of GSH in blood (p=0.02) and higher GR activity in blood (p=0.007). Only when combined with C-129T high risk genotype, the 7/7 GAG genotype induced a strong reduction of CGLC expression (p=0.045, bootstrapping 10000 samples). Gene expression related to glutathione synthesis was non-significantly (p=0.10-0.19) higher among patients. Levels of long-chain PUFA were significantly positively linked to gene expression of glutathione related enzymes. Discussion: The findings of abnormal levels of alpha-tocopherol, bilirubin, uric acid and glutathione synthesis in the chronic phase of schizophrenia indicate oxidative stress. Dysregulation of antioxidant defenses may be involved in the pathophysiology of schizophrenia and warrants further experimental studies. Background: Alterations in brain structure are among the most robust biological findings in schizophrenia. Also changes in fatty acid profiles including reduced levels of polyunsaturated fatty acids (PUFA) are well replicated in schizophrenia. Being essential for neurodevelopmental processes and structural plasticity and remodeling, alterations of PUFA metabolism might be also associated with the occurrence of brain structural abnormalities. To investigate this assumption in vivo we examined the interrelation of PUFA profiles and brain structure in neuroleptic naïve first-episode psychosis (FEP) patients and healthy controls (HC) matched for age and gender. Methods: High-resolution T1-weighted 3T MRI were acquired from 29 FEP patients (age 26.4 ± 5.3y; 13 females/16 males) and 31 HC (age 25.1 ± 4.7y; 14 f/17 m). Fatty acid profiles were analyzed using gas chromatography in the plasma phospholipid (PL) fraction that is rather independent of recent fat consumption, and that potentially indicates PUFA availability in phospholipid structural components essential in the brain.
To investigate brain structural abnormalities in FEP and effects of illness on interactions between fatty acid profiles and local grey (GM) or white (WM) matter density, voxel-based morphometry (VBM) with the computational anatomy toolbox (CAT12) was used. Results: VBM analyses revealed a reduction of GM in FEP in left frontal operculum, left middle frontal gyrus, left superior frontal gyrus and bilateral temporal gyrus (TFCE, FWE<0.05). The group comparisons of fatty acid profiles in the PL fraction showed reduced omega-6 PUFA and MCFA (C10-C14) levels in FEP patients. Interaction analyses revealed an influence of illness on the association between omega-6 PUFA and GM density at the left supramarginal gyrus/left postcentral gyrus and left superior temporal gyrus (TFCE, FWE<0.05) with a regression slope FEP patients > HC. For MCFA interaction analyses revealed effects of illness on associations with GM density in the bilateral superior medial frontal gyrus and left anterior cingulate gyrus with a regression slope HC > FEP patients. Discussion: Our results support the notion that the availability of PUFA and MCFA potentially affects brain structural development and remodeling. Background: According to the gene-environment interaction model the pathogenesis of psychosis relies on an adverse neuro-socio-developmental pathway. Perinatal stress represents an important risk factor for the development of psychosis because it could interfere with socio-neuro-development early in life. We aim to investigate the correlation of perinatal risk factors with the onset of psychosis. Methods: Case-control -incidence study. Patients (and their mothers) were eligible if they presented for the first time with first episode psychosis at the Bo West CMHC between 2002 and 2012. The Bo West CMHC serves a catchment area of about 200,000 people. The controls were recruited in the same catchment area and study period. Results: 42 patients and 26 controls and their mothers were included. Adjusted logistic regression showed that psychosis onset was significantly associated with: stressful situations during pregnancy; lower level of maternal physical health before or during pregnancy; use of anti-inflammatory drugs during pregnancy; low level of maternal education. Discussion: The results of our study suggest that stress during perinatal period increases the risk of developing psychosis. More attention should be given to the containment of perinatal stress and the prevention of its adverse effects on mother and child mental health. Tarricone Background: Dysfunctional attitudes such as defeatist performance beliefs (DPB) and asocial beliefs (AB) have been linked to negative symptoms and functional outcome in chronic schizophrenia (Campellone et al., 2016; Grant and Beck, 2010) and in adults with recent onset schizophrenia (Ventura et al., 2014) . Adolescents with early-onset psychosis (EOP) are at major risk of having persistent negative symptoms (Puig et al., 2017) but no previous study has examined dysfunctional attitudes in this population. We aimed: (1) to examine if more DPB and AB were present in adolescents with EOP compared with normal controls, and (2) to study the relationships between DPB and AB with symptoms and functioning. Methods: Sample: 15 adolescents with EOP (11♀, age=15.33 ± 1.23) and 10 healthy controls (8♀, age=15.60 ± 1.51), participants in a trial about cognitive and behavioral social skills treatment in EOP developing in Hospital Clínic of Barcelona (baseline data). Patients were under antipsychotic meds. Inclusion criteria: having an early-onset schizophrenia spectrum disorder diagnosed between 9-18 years-old (schizophrenia, schizoaffective disorder, psychosis n.o.s.); being within the 5 first years after the disease onset; clinical stability. Exclusion criteria: IQ<70; comorbid substance dependence disorder; neurological disorders. Instruments: PANSS (Kay et al., 1987) , Calgary Depression Scale (CDS, Addington et al., 1990 ), Children's Global Assessment Scale (C-GAS, Shaffer et al., 1983) , Social and Role Functioning Scales (GF:S, GF:R, Cornblatt et al., 2007) , Life Skills Profile -Adolescent version (Puig et al., 2013) , Dysfunctional Attitudes ScaleSpanish version (DAS, Sanz et al., 1993) ; Asocial Beliefs Scale (Grant and Beck, 2010) . DPB was extracted from the DAS scale following Beck et al. (2013) . Groups were compared with T-test or Chi-square tests. Pearson correlations were computed for examining relationships between variables. Results: EOP and control groups were homogeneous in age (t=-0.49, p=0.632) and sex (X2=0.15, p=0.702). All subjects were living with their parents. Family SES was lower in EOP group (X2=10.69, p=0.030). All subjects but one patient were studying although patients had repeated more courses (t=4.00, p=0.001). EOP subjects had a predominance of negative symptoms (positive symptoms=14.07 ± 3.85; negative symptoms=23.50 ± 13.79; general symptoms=31.86 ± 7.28). Mean score of CDS in EOP was low (3.77 ± 4.76). EOP group had lower scores in all functional measures than controls (C-GAS: 51.14 ± 9.38 vs 93.70 ± 4.45, GF:S: 5.71 ± 1.07 vs 9.00 ± 0.47, GF:R: 5.21 ± 1.12 vs 8. 80 ± 0.42, LSP: 67.64 ± 12.30 vs 44.13 ± 3.60; t>6.67, p<0.001) . Regarding dysfunctional attitudes, EOP group had higher scores in dysfunctional attitudes scales than healthy controls (DPB: 55.60 ± 19.57 vs 33.00 ± 9.37, AB: 6.67 ± 3.42 vs 3.00 ± 2.11; t>3.02, p<0.006). In EOP, DPB and AB scores were negatively correlated with functioning (DPB: C-GAS r=-0.60, GF:S r=-0.66, GF:R r=-0.66, LSP r=0.65; p<0.002; AB: C-GAS r=-0.45, GF:S r=-0.55, GF:R r=-0.49, LSP r=0.53; p<0.029). No significant correlation were found between dysfunctional attitudes and negative symptoms in EOP. Discussion: These preliminary results showed that adolescents with EOP had higher levels of dysfunctional attitudes than controls. Accordantly to recent literature, defeatists performance beliefs and asocial beliefs were correlated with poorer functioning. However, dysfunctional attitudes were not associated with negative symptoms. It might be that dysfunctional attitudes do not contribute to negative symptoms but in functional outcome in youngs with EOP although larger samples are required. Background: A child's parental bonding, measured using the Parental Bonding Instrument (PBI), has been found to be associated with psychiatric illnesses. In particular, a significantly higher proportion of patients with schizophrenia tend to report affectionless-controlling mothers as compared to healthy controls. This study aims to (i) investigate the applicability of the PBI tool in Singapore, using exploratory factor analysis, and (ii) explore the association between parental bonding, symptom severity and functioning across schizophrenia patients, individuals at ultra-high risk of psychosis (UHR), and healthy controls. Methods: Data from 59 schizophrenia patients, 164 UHR, and 510 healthy controls (N = 733) were collected. The Structured Clinical Interview for DSM-IV (SCID) was used to ascertain any psychiatric diagnoses. Positive and Negative Symptoms of Schizophrenia (PANSS) and Global Assessment of Functioning (GAF) were administered on UHR and patients. Social and Occupational Functioning Assessment Scale (SOFAS) was administered on HC and UHR. Calgary Depression Scale for Schizophrenia (CDSS) was administered on UHR only.
